Illustration: Shoshana Gordon/Axios
Optain Health raised $13 million to expand its robotic retinal imaging technology across U.S. health systems, CEO Jeff Dunkel tells Axios exclusively.
Why it matters: Retinal screening technology could help curb rising health costs by detecting disease earlier in routine care settings.